Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 4/2015

01-04-2015 | Erratum

Erratum to: Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer

Authors: Lampros Mitrakas, Stavros Gravas, Foteini Karasavvidou, Georgios Dimakopoulos, Georgios Moutzouris, Vasileios Tzortzis, Georgios Koukoulis, Christos Papandreou, Michael Melekos

Published in: Tumor Biology | Issue 4/2015

Login to get access

Excerpt

Erratum to: Tumor Biol. …
Metadata
Title
Erratum to: Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer
Authors
Lampros Mitrakas
Stavros Gravas
Foteini Karasavvidou
Georgios Dimakopoulos
Georgios Moutzouris
Vasileios Tzortzis
Georgios Koukoulis
Christos Papandreou
Michael Melekos
Publication date
01-04-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3286-5

Other articles of this Issue 4/2015

Tumor Biology 4/2015 Go to the issue

Research Article

Stoichiometric expression of MMP-2/TIMP-2 in benign and malignant tumours of the salivary gland

Research Article

Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer

Research Article

Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction

Research Article

MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met

Research Article

LASS2/TMSG1 inhibits growth and invasion of breast cancer cell in vitro through regulation of vacuolar ATPase activity

Research Article

Acquired resistance to EGFR tyrosine kinase inhibitor in A431 squamous cell carcinoma xenografts is mediated by c-Kit pathway transduction
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits